Inflammation impairs social cognitive processing: A randomized controlled trial of endotoxin

Brain, Behavior, and Immunity
Mona MoieniNaomi I Eisenberger

Abstract

Neuropsychiatric disorders (e.g., autism, schizophrenia) are partially characterized by social cognitive deficits, including impairments in the ability to perceive others' emotional states, which is an aspect of social cognition known as theory of mind (ToM). There is also evidence that inflammation may be implicated in the etiology of these disorders, but experimental data linking inflammation to deficits in social cognition is sparse. Thus, we examined whether exposure to an experimental inflammatory challenge led to changes in ToM. One hundred and fifteen (n=115) healthy participants were randomly assigned to receive either endotoxin, which is an inflammatory challenge, or placebo. Participants completed a social cognition task, the Reading the Mind in the Eyes (RME) test, at baseline and at the peak of the inflammatory response for the endotoxin group. The RME test, a validated measure of ToM, evaluates how accurately participants can identify the emotional state of another person by looking only at their eyes. We found that endotoxin (vs. placebo) led to decreases in performance on the RME test from baseline to the peak of inflammatory response, indicating that acute inflammation can lead to decreases in the ability to acc...Continue Reading

Associated Clinical Trials

References

Oct 1, 1985·Cognition·S Baron-CohenU Frith
Feb 1, 1996·Journal of Personality Assessment·D W Russell
Mar 31, 2001·Journal of Child Psychology and Psychiatry, and Allied Disciplines·S Baron-CohenI Plumb
May 16, 2001·Archives of General Psychiatry·A ReichenbergT Pollmächer
Jan 10, 2002·Brain, Behavior, and Immunity·S L BukaR H Yolken
Aug 31, 2002·Psycho-oncology·Frank BakerWilliam N Dudley
May 4, 2004·The American Journal of Psychiatry·Alan S BrownEzra S Susser
Oct 22, 2005·Neuroscience and Biobehavioral Reviews·Martin Brüne, Ute Brüne-Cohrs
Jul 3, 2007·The British Journal of Psychiatry : the Journal of Mental Science·Mirjam SprongHerman van Engeland
Apr 15, 2008·Schizophrenia Bulletin·Urs MeyerBenjamin K Yee
Aug 5, 2008·Current Medicinal Chemistry·A S AndreasenK Møller
Jan 13, 2009·Behavioural Brain Research·Paul H Patterson
Aug 12, 2009·Brain, Behavior, and Immunity·Amanda M EnstromPaul Ashwood
Apr 7, 2010·Behavioral Neuroscience·Christian J MerzJürgen Hennig
Jul 14, 2010·Neuroscience and Biobehavioral Reviews·Anne-Kathrin J FettLydia Krabbendam
Sep 14, 2010·Brain, Behavior, and Immunity·Paul AshwoodJudy Van de Water
Jun 7, 2011·Biological Psychiatry·Brian J MillerBrian Kirkpatrick
Sep 13, 2011·Brain, Behavior, and Immunity·Charity OnorePaul Ashwood
Dec 14, 2011·PloS One·Jan-Sebastian GrigoleitManfred Schedlowski
Jul 4, 2012·Developmental Neurobiology·Maximilian MichelKaroly Mirnics
Feb 19, 2013·Biological Psychiatry·Anna M Fineberg, Lauren M Ellman
Apr 23, 2013·Neurotoxicity Research·S RicciT Archer
Aug 29, 2013·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Mara M EpsteinBrenda M Birmann
Jun 28, 2014·The American Journal of Psychiatry·Sarah CanettaAlan S Brown
Jan 20, 2015·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Mona MoieniNaomi I Eisenberger

❮ Previous
Next ❯

Citations

Jan 24, 2016·Journal of Psychiatric Research·Giovanna Del Grande da SilvaRicardo Azevedo da Silva
Apr 2, 2016·Brain, Behavior, and Immunity·Keely A MuscatellNaomi I Eisenberger
Feb 22, 2017·CNS Spectrums·Trisevgeni DimopoulouEvangelia M Tsapakis
Dec 12, 2017·Translational Psychiatry·Sven BensonSigrid Elsenbruch
Jul 6, 2018·Annals of the New York Academy of Sciences·Lisa QuadtSarah N Garfinkel
Aug 17, 2020·Journal of Clinical Psychopharmacology·Robert W BuchananWilliam T Carpenter
Aug 3, 2016·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Naomi I EisenbergerMichael R Irwin
Sep 7, 2018·Frontiers in Behavioral Neuroscience·Simone KotullaSven Benson
Oct 11, 2019·Psychosomatic Medicine·Carrianne J Leschak, Naomi I Eisenberger
May 29, 2018·Annals of the New York Academy of Sciences·Mona Moieni, Naomi I Eisenberger
Jul 5, 2017·Frontiers in Psychiatry·Laura M RowlandDeanna L Kelly
Dec 9, 2020·Molecular Psychiatry·Carina CarbiaJohn F Cryan
Jan 23, 2021·Physiology & Behavior·Leonie Jt BalterJos A Bosch
Jun 13, 2020·Brain, Behavior, and Immunity·Dominique PiberMichael R Irwin
Jun 1, 2021·Current Opinion in Immunology·Weronika BarcikFrancesco Papaleo
Oct 9, 2021·Attachment & Human Development·Amanda VentaTodd Armstrong
Oct 31, 2021·Proceedings of the National Academy of Sciences of the United States of America·Richard McFarlandRobyn S Hetem

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autism

Autism spectrum disorder is associated with challenges with social skills, repetitive behaviors, and often accompanied by sensory sensitivities and medical issues. Here is the latest research on autism.

Autism: Treatment Targets

The absence of effective treatments for autism are due to the high clinical and genetic heterogeneity between affected individuals, restricted knowledge of the underlying pathophysiological mechanisms, and the lack of reliable diagnostic biomarkers. Identification of more homogenous biological subgroups is therefore essential for the development of novel treatments based on the molecular mechanisms underpinning autism and autism spectrum disorders. Find the latest research on autism treatment targets here.